help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evdokiou, A.
Right arrow Articles by Findlay, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evdokiou, A.
Right arrow Articles by Findlay, D. M.
Molecular Endocrinology 13 (10): 1738-1750
Copyright © 1999 by The Endocrine Society

Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells Is Accompanied by Induction of p21WAF1/CIP1 and G2/M Arrest

Andreas Evdokiou, Liza-Jane Raggatt, Gerald J. Atkins and David M. Findlay

Department of Orthopaedics and Trauma University of Adelaide The Royal Adelaide Hospital and the Hanson Centre for Cancer Research at the Institute for Veterinary and Medical Science Adelaide 5000, South Australia, Australia

We investigated the mechanisms by which calcitonin (CT) suppresses cellular proliferation, using HEK-293 cells stably transfected with either the rat C1a CT receptor (CTR) or the insert-negative form of the human CTR. CT treatment of clonal cell lines expressing either receptor type, but not untransfected HEK-293 cells, strongly suppressed cell growth in a concentration-dependent manner. The reduction in cell growth with CT treatment could not be attributed to cellular necrosis or apoptotic cell death, the latter assessed by both DNA fragmentation analysis and caspase 3 (CPP-32) assay. Growth inhibition was associated with an accumulation of cells in the G2 phase of the cell cycle. CT treatment of the human and rat CTR-expressing cell lines resulted in a rapid and sustained induction of mRNA encoding the cyclin-dependent kinase inhibitor, p21WAF1/CIP1, increased levels of which were maintained at least 48 h after initiation of treatment. Western blot analysis showed a rapid corresponding increase in p21WAF1/CIP1 protein, whereas protein levels of another member of the cyclin-dependent kinase inhibitor family, p27kip1, were unchanged. In parallel with the induction of p21, CT treatment reduced levels of p53 mRNA and protein. CT treatment resulted in a specific cell cycle block in G2, which was associated with inhibition of Cdc2/cyclin B kinase activity as measured by histone H1 phosphorylation. There was no evidence for p21 association with this complex despite the inhibition of Cdc2 activity. Evidence that p21 induction was causative of cell growth suppression was obtained from p21 antisense oligonucleotide experiments. Treatment with a p21 antisense oligonucleotide blocked induction of p21 expression and significantly reduced the CT-mediated growth inhibition. These observations suggest that p21 is required for the G2 arrest in response to CT, but argue against a direct role of p21 in the inhibition of Cdc2 activity. These studies suggest a novel regulation of cell cycle progression by CT and will provide a basis for detailed examination of the molecular mechanisms involved.




This article has been cited by other articles:


Home page
EndocrinologyHome page
L. E. C. Miles, A. C. Hanyaloglu, J. R. Dromey, K. D. G. Pfleger, and K. A. Eidne
Gonadotropin-Releasing Hormone Receptor-Mediated Growth Suppression of Immortalized L{beta}T2 Gonadotrope and Stable HEK293 Cell Lines
Endocrinology, January 1, 2004; 145(1): 194 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. de Belle, J.-X. Wu, S. Sperandio, D. Mercola, and E. D. Adamson
In Vivo Cloning and Characterization of a New Growth Suppressor Protein TOE1 as a Direct Target Gene of Egr1
J. Biol. Chem., April 11, 2003; 278(16): 14306 - 14312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. M. Devlin, N. Solban, S. Tremblay, J. Gutkowska, W. Schurch, S. N. Orlov, R. Lewanczuk, P. Hamet, and J. Tremblay
HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F753 - F762.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z.-y. Huang, Y. Wu, N. Hedrick, and D. H. Gutmann
T-Cadherin-Mediated Cell Growth Regulation Involves G2 Phase Arrest and Requires p21CIP1/WAF1 Expression
Mol. Cell. Biol., January 15, 2003; 23(2): 566 - 578.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. Moffatt, W. U. Johannes, T. E. Hedlund, and G. J. Miller
Growth Inhibitory Effects of 1{alpha}, 25-Dihydroxyvitamin D3 Are Mediated by Increased Levels of p21 in the Prostatic Carcinoma Cell Line ALVA-31
Cancer Res., October 1, 2001; 61(19): 7122 - 7129.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
B. A. Shin, K. Y. Ahn, H. Kook, J. T. Koh, I. C. Kang, H. C. Lee, and K. K. Kim
Overexpressed Human RAD50 Exhibits Cell Death in a p21WAF1/CIP1-dependent Manner: Its Potential Utility in Local Gene Therapy of Tumor
Cell Growth Differ., May 1, 2001; 12(5): 243 - 254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society